What is the appropriate approach to assess and manage restlessness in critically ill patients?

Management of Restlessness in Critically Ill Patients

Assess and treat pain first using validated tools, then target light sedation with an analgesia-first approach using short-acting agents (propofol or dexmedetomidine) while avoiding benzodiazepines, and implement multicomponent nonpharmacologic interventions to address underlying causes of restlessness. 1

Assessment Framework

Step 1: Rule Out and Treat Pain

• Pain must be assessed and treated before considering sedation 2
• Use validated pain assessment tools routinely
• Implement protocol-based, stepwise pain management before reaching for sedatives 2
• Untreated pain is a primary driver of restlessness and agitation in the ICU 1

Step 2: Assess for Delirium

• Regularly screen for delirium using validated tools (CAM-ICU or ICDSC) 2
• Delirium manifests as restlessness, agitation, and confusion
• Distinguish between hyperactive delirium (agitation) versus hypoactive delirium
• Environmental stressors, sleep deprivation, and immobility all contribute to delirium 2

Step 3: Identify Reversible Causes

Look for:

• Inadequate analgesia
• Hypoxia or ventilator dyssynchrony
• Urinary retention or constipation
• Medication withdrawal (especially alcohol or benzodiazepines)
• Environmental factors (noise, light, lack of reorientation)

Pharmacologic Management

Sedation Strategy

Target light sedation over deep sedation 2

• Light sedation reduces mechanical ventilation duration, ICU length of stay, and mortality
• Deep sedation contributes to muscle weakness, delirium, and prolonged ventilation 1

Agent Selection (in order of preference)

First-line: Propofol or Dexmedetomidine over benzodiazepines 2

• Both are superior to benzodiazepines for reducing delirium and improving outcomes
• Benzodiazepines should be avoided except for alcohol/sedative withdrawal 1, 3

For agitation precluding ventilator weaning:

• Use dexmedetomidine specifically when agitation prevents extubation 2
• This is a conditional recommendation with low-quality evidence, but dexmedetomidine increases ventilator-free hours 2

Antipsychotics: Limited Role

Do NOT routinely use haloperidol or atypical antipsychotics for delirium treatment 2

• They do not improve delirium outcomes in randomized trials
• Exception: Short-term use may be warranted for patients with severe distress from hallucinations/delusions or agitation causing physical harm to self/others 2
• Discontinue immediately once distressful symptoms resolve 2

Critical Pitfall: Avoid Combination Therapy

• Combination therapy (benzodiazepines + antipsychotics) increases oversedation, hypotension, and prolonged mechanical ventilation 3
• Current PADIS guidelines do not recommend routine combination therapy 3

Nonpharmacologic Interventions

Implement multicomponent strategies targeting modifiable risk factors 2

Core Components:

• Reorientation and cognitive stimulation (clocks, calendars, verbal reorientation)
• Sleep optimization: Minimize nighttime noise and light, cluster care activities 2
• Early mobilization: Reduces ICU-acquired weakness and delirium 2
• Hearing and vision optimization: Ensure glasses and hearing aids are available
• Family engagement: Family presence helps with reorientation and reduces anxiety 1
• Environmental modifications: Earplugs, eyeshades, and reducing unnecessary stimuli 2

Specific Interventions:

• Use of familiar family photographs may reduce restlessness after the first night 4
• Avoid physical restraints when possible; they often worsen agitation 5

Implementation Algorithm

1. Assess pain → Treat with multimodal analgesia (opioids + adjuncts like acetaminophen, neuropathic agents) 2

2. Screen for delirium → Identify and address reversible causes

3. If sedation needed:

   • Choose propofol or dexmedetomidine
   • Target light sedation (patient arousable, able to follow commands)
   • Avoid benzodiazepines unless treating withdrawal 1, 2

4. If agitation prevents weaning:

   • Consider dexmedetomidine specifically 2

5. Implement nonpharmacologic bundle:

   • Daily awakening trials + spontaneous breathing trials
   • Early mobilization
   • Sleep hygiene
   • Family engagement 1, 2

6. Reserve antipsychotics only for severe distress with hallucinations or dangerous agitation 2

Key Warnings

• Deep sedation is harmful and should be avoided 1, 2
• Benzodiazepines worsen delirium and prolong ICU stay 1, 3
• The COVID-19 pandemic led to regression in best practices (deeper sedation, more benzodiazepines); these practices must be actively reversed 1
• Sleep deprivation contributes to delirium, but evidence for sleep-promoting medications (melatonin, dexmedetomidine at night) is insufficient to make recommendations 2